Localization of the cellular expression of inhibin in trophoblastic tissue

Histopathology

Volumn 32, Issue 3, 1998, Pages 252-256

  Mccluggace, W G ^a   Ashe, P ^a   Mcbride, H ^a   Maxwell, P ^a   Sloan, J M ^a,b  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Cytotrophoblast; Immunohistochemistry; Inhibin; Syncytiotrophoblast

Indexed keywords

INHIBIN;

ARTICLE; CHORIOCARCINOMA; EMBRYO; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST; TISSUE DISTRIBUTION; TROPHOBLAST;

CARCINOMA, EMBRYONAL; CHORIOCARCINOMA; CHORIONIC VILLI; DECIDUA; FEMALE; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; INHIBINS; MALE; PREGNANCY; PREGNANCY, ECTOPIC; TESTICULAR NEOPLASMS; TROPHOBLASTS; UTERINE NEOPLASMS;

EID: 0031913237     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1998.00385.x     Document Type: Article

References (35)

1. McLachlan RI, Robertson DM, Burger HG, de Kretsel DM. Circulating immunoreactive inhibin levels during the normal menstrual cycle. J. Clin. Endocrinol. Metab. 1987: 65; 954-961.
2. Lappohn RE, Burger HG, Bouma J, Bangah M, Kraus M, de Bruijn HWA. Inhibin as a marker for granulosa cell tumors. N. Eng. J. Med. 1989: 321; 790-793.
3. Cooke I, O'Brien MO, Charnock FM, Groome N, Ganesan TS. Inhibin as a marker for ovarian cancer. Br. J. Cancer 1995: 71; 1046-1050.
4. McCluggage WG, Maxwell P, Sloan JM. Immunohistochemical staining of ovarian granulosa cell tumours with monoclonal antibody against inhibin. Hum. Pathol. 1997: 28; 1034-1038.
5. Flemming P, Wellmann A, Maschek H, Lang H, Georgii A. Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. Am. J. Surg. Pathol 1995: 19; 927-933.
6. Stewart CJR, Jeffers MD, Kennedy A. Diagnostic value of inhibin immunoreactivity in ovarian gonadal stromal tumours and their histological mimics. Histopathology 1997: 31; 67-74.
7. McLachlan RI, Healy DL, Robertson DM, Burger HG, de Kretser DM. Circulating immunoreactive inhibin in the luteal phase and early gestation of women undergoing ovulation induction. Fertil. Steril. 1987: 48; 1001-1005.
8. Abe Y, Hasegawa Y, Miyamoto K et al. High concentrations of plasma immunoreactive inhibin during normal pregnancy in women. J. Clin. Endocrinol. Metab. 1990: 71; 133-137.
9. Qu J, Vankrieken L, Brulet C, Thomas K. Circulating bioactive inhibin levels during human pregnancy. J. Clin. Endocrinol. Metab. 1991: 72; 862-866.
10. Yamoto M, Minami S, Nakano R. Immunohistochemical localization of inhibin subunits in human corpora lutea during menstrual cycle and pregnancy. J. Clin. Endocrinol. Metab. 1991: 73; 470-477.
11. Mayo KE. Cereli GM. Spiess J et al. Inhibin A - subunit of cDNAs from porcine ovary and human placenta. Proc. Natl. Acad. Sci. USA 1986: 83; 5849-5853.
12. McLachlan RI. Healy DL, Robertson DM, Burger HG, de Kretser DM. The human placenta: A novel source of inhibin. Biochem. Biophys. Res. Commun. 1986: 140; 485-490.
13. Minami S, Yamoto M, Nakano R. Immunohistochemical localization of inhibin/activin subunits in human placenta. Obstet. Gynecol. 1992; 80: 410-414.
14. Petralglia F. Sawchenko P. Lin ATW, Rivier J, Vale W. Localization, secretion and action of inhibin in human placenta. Science 1987: 237; 187-189.
15. Petraglia F. Garuti GC. Calza L et al. Inhibin subunits in human placenta: localization and messenger ribonucleic acid levels during pregnancy. Am. J. Obstet. Gynecol. 1991: 165; 750-758.
16. Petraglia F. Calza L. Garuti GC et al. Presence and synthesis of inhibin subunits in human decidua. J. Clin. Endocrinol. Metab. 1990: 71; 487-492.
17. Arora DS, Cooke IE, Ganesan TS et al. Immunohistochemical expression of inhibin/activin subunits in epithelial and granulosa cell tumours of the ovary. J. Pathol. 1997: 181; 413-418.
18. Ruseff SJ. Bangah ML, Kettel L et al. Dynamic change in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle. J. Clin. Endocrinol. Metab. 1989: 69; 1033-1039.
19. Tsonis CG, Messinis IE, Templeton AA, McNelly AS, Baird DT. Gonadotrophic stimulation of inhibin secretion by the human ovary during the follicular and early luteal phase of the cycle. J. Clin. Endocrinol. Metab. 1988: 66; 915-921.
20. Gosseye S, Fox H. An immunohistochemical comparison of the secretory capacity of villous and extravillous trophoblast in the human placenta. Placenta 1984: 5; 329-348.
21. Horne CHW, Rankin R, Bremner RD. Pregnancy-specific proteins as marker for gestational trophoblastic disease. Int. J. Gynecol. Pathol. 1984: 3; 27-40.
22. Silverberg SG, Kurman RJ. Gestational trophoblastic disease. In Silverberg SG and Kurman RJ eds. Tumors of the Uterine Corpus and Gestational Trophoblastic Disease. Washington D.C.: Armed Forces Institute of Pathology, 1992: 219-232.
23. Kurman RJ, Main CS, Chen HC. Intermediate trophoblast: a distinctive form of trophoblast with specific morphological. biochemical and functional features. Planceta 1984: 5; 349-370.
24. Kurman RJ, Young RH, Norris HJ, Main CS, Lawrence WD. Scully RE. Immunocytochemical localization of placental lactogen and chorionic gonadotrophin in the normal placenta and trophoblastic tumors with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. Int. J. Gynecol. Pathol. 1984: 3; 101-121.
25. Wells M, Bulmer JN. The human placental bed: histology, immunohistochemistry and pathology. Histopathology 1988: 13; 483-498.
26. Pijenborg R, Dixon G, Robertson WB. Brosens I. Trophoblastic invasion of human decídua from 8 to 18 weeks of pregnancy, Placenta 1980: 1; 3-19.
27. Bulmer JN, Wells M. Bhabra K et al. Immunohistological characterisation of endometrial gland epithelium and extravillous fetal trophoblast in third trimester human placental bed tissues. Br. J. Obstet. Gynecol. 1986: 93; 823-832.
28. Sasagawa M, Watanabe S, Ohmono Y et al. Reactivity of two monoclonal antibodies (Troma 1 and CAM 5.2) on human tissue sections: analysis of their usefulness as a histological trophoblast marker in normal pregnancy and trophoblastic disease. Int. J. Gynecol. Pathol. 1986: 5; 345-356.
29. Daya D, Sabet L. The use of cytokeratin as a sensitive and reliable marker for trophoblastic tissue. Am. J. Clin. Pathol. 1991: 95; 137-141.
30. Heatley MK, Maxwell P, Toner TG. The immunophenotype of human decidua and extra-uterine decidual reactions. Histopathology 1996: 29; 437-442.
31. Golanden A, Hurley T, Barrett J, Hizi A, Handwerger S. Prolactin synthesis by human-chorion-decidual tissue: a possible source of prolactin in the amniotic fluid. Science 1978: 202; 311-313.
32. Kumasaka T, Nishi N. Yaoi Y et al. Demonstration of immunoreactive somatostatin-like substance in villi and decidua in early pregnancy. Am. J. Obstet. Gynecol. 1979: 134; 39-44.
33. Bryant-Greenwood DG. Relaxin as a new hormone. Endocr. Rev. 1982: 3; 62-80.
34. Yohkaichiya T, Fukaya T, Hoshiai H, Yajima A. de Kretser DM. Inhibin: a new circulating marker of hydatidiform mole? Br. Med. J. 1989: 298; 1684-1686.
35. Minami S, Yamoto M, Nakano AR. Immunohistochemical localization of inhibin-activin subunits in hydatidiform mole and invasive mole. Obstet. Gynecol. 1993: 82; 414-418.